MTD vs. NVO

In the year-to-date period, MTD achieves a -4.31% return, which is significantly lower than NVO's 0.30% return. Over the past 10 years, MTD has underperformed NVO with an annualized return of 14.77%, while NVO has yielded a comparatively higher 18.98% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Mettler-Toledo International Inc. (MTD) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MTD Sharpe Ratio is 0.32, which is higher than the NVO Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of MTD and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

MTD has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.41%.

The maximum MTD drawdown since its inception was -61.43%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for MTD and NVO. For additional features, visit the drawdowns tool.

Mettler-Toledo International Inc. (MTD) has a higher volatility of 11.53% compared to Novo Nordisk A/S (NVO) at 7.89%. This indicates that MTD's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Mettler-Toledo International Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.